China Pharma Holdings CPHI
NYSE CPHI
$0.67 -0.05 (-6.91%)
As of: Sep 29, 2026 · 3:57 PM EDT

China Pharma Holdings (CPHI) Accounts Payables (2010 - 2026)

Updated

China Pharma Holdings' Accounts Payables came in at $734,042 for Q2 2026, up 38.3% from $530,729 a year earlier but down 12.3% from the prior quarter.

Analysis

China Pharma Holdings (CPHI) Accounts Payables (2010 - 2026) Analysis & Trends

At the end of FY2025, China Pharma Holdings' Accounts Payables was $891,083, up 295.9% from FY2024.

  • Accounts Payables carries a five-year compound annual growth rate of -6.3% (FY2020 to FY2025).
  • Going back by year, Accounts Payables was $225,106 in FY2024 (-76.7%), $966,420 in FY2023 (+44.9%), $667,082 in FY2022 (-28.0%) and $926,749 in FY2021 (-24.9%).
  • The five-year range for quarterly Accounts Payables is $141,036 (Q2 2024) to $966,420 (Q4 2023).
  • Year-over-year, Accounts Payables has increased for five consecutive quarters, with growth averaging 71.1% over the last eight quarters.
  • The fastest year-over-year change in Accounts Payables over five years came in Q4 2025 (growth of 295.9%), and the weakest in Q4 2024 (a decline of 76.7%).
  • Business Quant data shows CPHI's Accounts Payables at $837,108 (Q1 2026), $891,083 (Q4 2025) and $588,739 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 9.22 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.30 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -22.89 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 674.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 429.50 Mn
10 China Pharma Holdings 29.58 Mn 28.46 Mn 83,566.00 734,042.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 734,042.00
Mar 31, 2026 837,108.00
Dec 31, 2025 891,083.00
Sep 30, 2025 588,739.00
Jun 30, 2025 530,729.00
Mar 31, 2025 548,257.00
Dec 31, 2024 225,106.00
Sep 30, 2024 390,239.00
Jun 30, 2024 141,036.00
Mar 31, 2024 647,828.00
Dec 31, 2023 966,420.00
Sep 30, 2023 831,298.00
Jun 30, 2023 414,084.00
Mar 31, 2023 851,882.00
Dec 31, 2022 667,082.00
Sep 30, 2022 435,608.00
Jun 30, 2022 397,543.00
Mar 31, 2022 927,350.00
Dec 31, 2021 926,749.00
Sep 30, 2021 683,154.00
API Access

China Pharma Holdings Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=CPHI&period=max&api_key=YOUR_API_KEY